PAH patients may ditch frequent inhaler for Once-Daily pill
NCT ID NCT07356375
First seen Jan 22, 2026 · Last updated May 15, 2026 · Updated 18 times
Summary
This study looks at whether changing from an inhaled medication (iloprost) to a pill (selexipag) can improve quality of life and treatment satisfaction for people with pulmonary arterial hypertension (PAH). About 32 adults whose doctor has already decided to switch treatments will be followed over time, along with a comparison group staying on the inhaler. The goal is to see if the easier pill routine helps patients feel better and stick with their treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.